Authors:
BURTON PS
GOODWIN JT
CONRADI RA
HO NFH
HILGERS AR
Citation: Ps. Burton et al., IN-VITRO PERMEABILITY OF PEPTIDOMIMETIC DRUGS - THE ROLE OF POLARIZEDEFFLUX PATHWAYS AS ADDITIONAL BARRIERS TO ABSORPTION, Advanced drug delivery reviews, 23(1-3), 1997, pp. 143-156
Authors:
BURTON PS
CONRADI RA
HO NFH
HILGERS AR
BORCHARDT RT
Citation: Ps. Burton et al., HOW STRUCTURAL FEATURES INFLUENCE THE BIOMEMBRANE PERMEABILITY OF PEPTIDES, Journal of pharmaceutical sciences, 85(12), 1996, pp. 1336-1340
Authors:
CONRADI RA
HILGERS AR
BURTON PS
HESTER JB
Citation: Ra. Conradi et al., EPITHELIAL-CELL PERMEABILITY OF A SERIES OF PEPTIDIC HIV PROTEASE INHIBITORS - AMINOTERMINAL SUBSTITUENT EFFECTS, Journal of drug targeting., 2(2), 1994, pp. 167-171
Authors:
PATERSON DA
CONRADI RA
HILGERS AR
VIDMAR TJ
BURTON PS
Citation: Da. Paterson et al., A NONAQUEOUS PARTITIONING SYSTEM FOR PREDICTING THE ORAL ABSORPTION POTENTIAL OF PEPTIDES, Quantitative structure-activity relationships, 13(1), 1994, pp. 4-10
Authors:
ADSON A
RAUB TJ
BURTON PS
BARSUHN CL
HILGERS AR
AUDUS KL
HO NFH
Citation: A. Adson et al., QUANTITATIVE APPROACHES TO DELINEATE PARACELLULAR DIFFUSION IN CULTURED EPITHELIAL-CELL MONOLAYERS, Journal of pharmaceutical sciences, 83(11), 1994, pp. 1529-1536
Authors:
CONRADI RA
WILKINSON KF
RUSH BD
HILGERS AR
RUWART MJ
BURTON PS
Citation: Ra. Conradi et al., IN-VITRO IN-VIVO MODELS FOR PEPTIDE ORAL ABSORPTION - COMPARISON OF CACO-2 CELL-PERMEABILITY WITH RAT INTESTINAL-ABSORPTION OF RENIN INHIBITORY PEPTIDES, Pharmaceutical research, 10(12), 1993, pp. 1790-1792
Citation: Ra. Conradi et al., THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS .2. PEPTIDE-BOND MODIFICATION WHICH RESULTS IN IMPROVED PERMEABILITY, Pharmaceutical research, 9(3), 1992, pp. 435-439
Authors:
BURTON PS
CONRADI RA
HILGERS AR
HO NFH
MAGGIORA LL
Citation: Ps. Burton et al., THE RELATIONSHIP BETWEEN PEPTIDE STRUCTURE AND TRANSPORT ACROSS EPITHELIAL-CELL MONOLAYERS, Journal of controlled release, 19(1-3), 1992, pp. 87-97